Paulo F. Costa is Director at AMYLIN PHARMACEUTICALS INC (AMLN). They have made 1 open-market trade across 1 company since 2016, most recently 2023-05-17.
CIK 0001465928
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $172K since 2016, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MGNX | BUY | 2016-03-03 | 2016-03-04 | $17.20 | $172K | -13.7% | +7.7% | +49.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.